Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -51.55%1.24M | -112.42%-695.87K | 32.29%18.23M | 34.67%5.1M | 78.62%4.96M | -49.43%2.57M | 161.94%5.6M | 2,028.90%13.78M | 1,123.27%3.79M | 191.32%2.78M |
| Net income from continuing operations | -768.02%-8.32M | -102.01%-44.43K | 178.68%6.83M | 476.85%4.59M | -369.44%-1.22M | -63.39%1.25M | 1,280.81%2.21M | 210.71%2.45M | -267.24%-1.22M | 126.01%453K |
| Operating gains losses | ---- | ---- | 145.01%55.88K | --24.84K | ---- | ---- | ---- | --22.81K | ---- | ---- |
| Depreciation and amortization | 75.05%1.78M | -33.44%1.91M | 49.10%7.8M | 34.36%2.26M | 1.06%1.66M | -27.77%1.02M | 473.63%2.86M | 179.50%5.23M | 185.64%1.68M | 349.23%1.64M |
| Asset impairment expenditure | --156.75K | --635.6K | 5.64%745.58K | -200.43%-407.5K | 668.72%1.15M | --0 | --0 | -47.72%705.77K | -69.94%405.77K | --150K |
| Remuneration paid in stock | 118.21%20.06K | -237.74%-168.45K | 97.63%-11.24K | 136.01%122.53K | 78.34%-145.93K | -190.58%-110.14K | -70.68%122.29K | -127.62%-475.32K | 21.89%-340.29K | -131.24%-673.77K |
| Remuneration paid in stock | 259.38%276.55K | -65.27%145.32K | 1,137.01%764.19K | --132.93K | --135.89K | 24.56%76.95K | --418.42K | --61.78K | --0 | --0 |
| Deferred tax | -3.46%335.39K | -202.43%-774.09K | 152.30%884.16K | 2,803.28%478.29K | -6.74%-697.27K | 164.75%347.4K | 256.46%755.73K | -15.09%-1.69M | 95.97%-17.69K | 36.60%-653.21K |
| Other non cashItems | 541.35%8.79M | 1,055.08%1.34M | -24.27%5.11M | -90.77%195.93K | 46.26%3.69M | 571.42%1.37M | -105.86%-140.4K | 152.10%6.75M | 490.65%2.12M | 283.12%2.52M |
| Change In working capital | -34.22%-1.38M | -302.21%-2.5M | -251.51%-3.31M | -164.27%-1.66M | 100.72%4.8K | -148.60%-1.03M | 66.44%-622.08K | 146.89%2.18M | 430.42%2.59M | -221.75%-662.8K |
| -Change in receivables | 10.07%-2M | 18,489.86%2.8M | -168.72%-3.05M | -152.51%-660.65K | -111.93%-175.24K | -153.63%-2.22M | 100.62%15.06K | 772.54%4.43M | 111.38%1.26M | 165.10%1.47M |
| -Change in inventory | -325.99%-1.07M | 106.14%101.29K | -348.67%-7.27M | -100.83%-1.4M | -379.88%-3.96M | -110.89%-251.22K | 31.29%-1.65M | 70.83%-1.62M | 73.80%-698.82K | -12.94%-826.02K |
| -Change in prepaid assets | -8,561.29%-1.85M | 1,359.12%45.69K | 266.28%1.35M | 113.78%11.26K | 1,097.53%1.36M | 95.53%-21.41K | 102.71%3.13K | -338.85%-812.35K | 50.97%-81.68K | -619.65%-136.12K |
| -Change in payables and accrued expense | 141.23%3.55M | -639.57%-5.45M | 2,993.42%5.66M | -81.45%391.14K | 338.25%2.79M | 138.06%1.47M | -67.50%1.01M | -89.52%182.88K | 44.77%2.11M | -257.88%-1.17M |
| Tax refund paid | -18.44%-416.95K | ---1.23M | 56.04%-639.94K | ---- | ---- | ---352.02K | --0 | ---1.46M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -51.55%1.24M | -112.42%-695.87K | 32.29%18.23M | 34.67%5.1M | 78.62%4.96M | -49.42%2.57M | 161.82%5.6M | 2,028.90%13.78M | 1,123.27%3.79M | 191.32%2.78M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -322.16%-1.4M | 78.89%-406.18K | -148.07%-5.48M | -253.36%-1.85M | 31.82%-1.38M | -150.91%-331.91K | -503.46%-1.92M | -133.45%-2.21M | -1,963.46%-523.91K | -1,850.36%-2.02M |
| Net PPE purchase and sale | -322.16%-1.4M | 78.89%-406.18K | -70.05%-5.48M | -253.36%-1.85M | 28.64%-1.38M | 26.64%-331.91K | -503.46%-1.92M | -579.11%-3.23M | -13,832.98%-523.91K | -1,647.08%-1.93M |
| Net business purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --1.01M | --0 | ---90K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -322.16%-1.4M | 78.89%-406.18K | -148.07%-5.48M | -253.36%-1.85M | 28.64%-1.38M | -159.07%-331.91K | -503.46%-1.92M | -133.45%-2.21M | -1,963.46%-523.91K | -1,763.47%-1.93M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 81.14%-230.18K | 55.38%-1.24M | 21.01%-8.42M | 64.21%-1.06M | -10.17%-3.36M | 63.55%-1.22M | -114.89%-2.77M | -754.30%-10.66M | -236.99%-2.97M | -453.06%-3.05M |
| Net issuance payments of debt | -63.01%-1.99M | 55.38%-1.24M | 21.01%-8.42M | 64.21%-1.06M | -10.17%-3.36M | 63.55%-1.22M | -114.89%-2.77M | -754.30%-10.66M | -236.99%-2.97M | -453.06%-3.05M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 81.14%-230.18K | 55.38%-1.24M | 21.01%-8.42M | 64.21%-1.06M | -10.17%-3.36M | 63.55%-1.22M | -114.89%-2.77M | -754.30%-10.66M | -236.99%-2.97M | -453.06%-3.05M |
| Net cash flow | ||||||||||
| Beginning cash position | 48.07%3.34M | 320.15%5.68M | 209.02%1.35M | 231.33%3.49M | 0.44%3.27M | 133.21%2.26M | 209.02%1.35M | -7.01%437.55K | 7.64%1.05M | 377.92%3.26M |
| Current changes in cash | -138.06%-386.74K | -358.78%-2.34M | 373.31%4.33M | 634.94%2.19M | 110.06%221.7K | -55.64%1.02M | 70.61%904.25K | 2,870.79%914.58K | 154.88%297.54K | -839.53%-2.2M |
| End cash Position | -9.73%2.95M | 48.07%3.34M | 320.15%5.68M | 320.15%5.68M | 231.33%3.49M | 0.44%3.27M | 133.21%2.26M | 209.02%1.35M | 209.02%1.35M | 7.64%1.05M |
| Free cash from | -107.00%-156.57K | -129.96%-1.1M | 14.23%12.05M | -21.59%2.55M | 323.21%3.58M | -51.64%2.24M | 102.00%3.68M | 920.85%10.55M | 1,398.92%3.26M | 0.45%846.39K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.